A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 12,985 shares of AMGN stock, worth $3.67 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
12,985
Previous 15,477 16.1%
Holding current value
$3.67 Million
Previous $4.84 Million 13.49%
% of portfolio
0.12%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $770,974 - $840,750
-2,492 Reduced 16.1%
12,985 $4.18 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $2.1 Million - $2.55 Million
7,979 Added 106.42%
15,477 $4.84 Million
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $500,098 - $603,681
1,860 Added 32.99%
7,498 $2.13 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $162,880 - $183,749
637 Added 12.74%
5,638 $1.62 Million
Q3 2023

Nov 02, 2023

BUY
$218.65 - $271.46 $26,893 - $33,389
123 Added 2.52%
5,001 $1.34 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $202,485 - $239,434
-945 Reduced 16.23%
4,878 $1.08 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $67,737 - $82,560
300 Added 5.43%
5,823 $1.41 Million
Q3 2022

Nov 02, 2022

SELL
$224.46 - $253.15 $71,602 - $80,754
-319 Reduced 5.46%
5,523 $1.25 Million
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $121,584 - $135,301
527 Added 9.92%
5,842 $1.42 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $137,701 - $152,333
-628 Reduced 10.57%
5,315 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $100,036 - $114,482
503 Added 9.25%
5,943 $1.34 Million
Q3 2021

Nov 02, 2021

SELL
$212.27 - $248.7 $21,439 - $25,118
-101 Reduced 1.82%
5,440 $1.16 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $608,709 - $675,318
2,606 Added 88.79%
5,541 $1.35 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $452,918 - $527,802
-2,041 Reduced 41.02%
2,935 $730,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $38,732 - $46,122
-179 Reduced 3.47%
4,976 $1.14 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $42,471 - $47,231
-181 Reduced 3.39%
5,155 $1.31 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $28,286 - $34,711
-143 Reduced 2.61%
5,336 $1.26 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $13,485 - $17,885
74 Added 1.37%
5,479 $1.11 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $12,677 - $16,294
-67 Reduced 1.22%
5,405 $1.3 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $168,190 - $201,526
966 Added 21.44%
5,472 $1.06 Million
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $51,510 - $60,381
-309 Reduced 6.42%
4,506 $830,000
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $98,031 - $110,502
542 Added 12.68%
4,815 $915,000
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $133,264 - $155,562
747 Added 21.19%
4,273 $832,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $8,708 - $9,817
-47 Reduced 1.32%
3,526 $731,000
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $81,198 - $91,203
-489 Reduced 12.04%
3,573 $660,000
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $68,788 - $80,388
-406 Reduced 9.09%
4,062 $692,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $229,747 - $268,488
1,356 Added 43.57%
4,468 $692,000
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $11,646 - $13,012
69 Added 2.27%
3,112 $541,000
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $167 - $191
1 Added 0.03%
3,043 $567,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,042
3,042 $524,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.